Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 16 at 2:00 PM EDT

Register Free →

Rutgers, The State University Of New Jersey NJ 08901-8559 USA

UEI: SLED_B98E4B63F8B895B8

Rutgers, The State University Of New Jersey NJ 08901-8559 USA is a federal contractor, registered under UEI SLED_B98E4B63F8B895B8. It has been awarded $676,840 across 1 federal contract. Primary work spans Research and Development in Biotechnology (except Nanobiotechnology). Top awarding agencies include National Institutes Of Health Nichd.

Contact Information

Registration and classification details

Registration

UEI Code

SLED_B98E4B63F8B895B8

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

Key Performance Metrics

Awards Count

0

All time

Active

0

Currently performing

Completed

0

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award Analytics & Distribution

Awards by Agency
National Institutes Of Health Nichd$676.8K100%
Awards by NAICS
541714 - Research and Development in Biotechnology (except Nanobiotechnology)$676.8K100%
Awards by Agency Over Time
Awards by Place of Performance

Compete with Rutgers, The State University Of New Jersey NJ 08901-8559 USA

Track the contractors you bid against, and the work they win

Award history, agency mix, and NAICS coverage for Rutgers, The State University Of New Jersey NJ 08901-8559 USA

AI-powered matching against your own capabilities and past performance

Teaming and subcontracting signals on every award

Automated alerts when a competitor wins in your market

Miguel
Hillary
Keith Deutsch
Christine

Join 650+ contractors already using CLEATUS

Open opportunities in Rutgers, The State University Of New Jersey NJ 08901-8559 USA's top NAICS codes and agencies

NAICS: 541714
New
Federal
AMPLICON SEQUENCING SERVICES
Solicitation # 140G0226Q0047
Solicitation 140G0226Q0047 is a firm-fixed-price Blanket Purchase Agreement (BPA) issued by the USGS Office of Acquisition Grants-Denver for next-generation amplicon sequencing services to support the Michigan Bacteriological Research Laboratory. The BPA has a not-to-exceed value of 250,000 USD and an estimated period of performance from September 17, 2026, through September 16, 2031. The scope of work includes library preparation for 16S V4 amplicon sequencing, library pooling via qPCR, and sequencing using Illumina MiSeq or AVITI platforms. Key technical requirements specify the use of 515F and 806R 16S rRNA primers, with strict quality standards for read pairs and quality scores. Deliverables include demultiplexed raw sequencing data, detailed data spreadsheets, and a comprehensive methods document, all of which must be delivered within 60 business days of sample receipt. The award process prioritizes non-priced technical factors over cost, evaluating offerors based on their on-site equipment, personnel experience, internal QA/QC procedures, and a two-page capabilities narrative. Additionally, offerors must provide two customer references from the last five years. Contract administration requires electronic invoicing through the Treasury's Internet Payment Platform and adherence to the Prompt Payment Act. The agreement is governed by various FAR clauses, including those regarding small business representations, Buy American certification, and prohibitions on specific telecommunications equipment. Performance is based on a Statement of Work and a Quality Assurance Surveillance Plan, with the government reserving the right to require the re-performance of nonconforming services at no additional cost.
Ofc Of Acquisition Grants-Denver

POSTED

1 day ago

DEADLINE

in 1 day
View Details
NAICS: 334510
New
Federal
Equipment: 7T MRI System with a dedicated, high-performance, local gradient subsystem.
Solicitation # RFP-2026-NIH-7TMR
The National Institutes of Health (NIH) is seeking a single-award, Firm-Fixed-Price contract for the acquisition and turn-key installation of a research-dedicated 7-Tesla (7T) Ultra-High Field Magnetic Resonance Imaging (MRI) system at the Functional Magnetic Resonance Imaging Core (FMRIF) Center in Bethesda, Maryland. The scope of work includes the delivery of the MRI system with a high-performance local gradient subsystem, professional project management, specialized rigging and mechanical installation within Building 10, and the de-installation and removal of an existing legacy Siemens 7T Plus system. The contractor is responsible for all equipment, personnel, calibration, and onsite applications training, with a total period of performance spanning 18 to 24 months from the date of award. Technical requirements are stringent, mandating a superconducting actively shielded 7.0T magnet, specific field homogeneity and drift rates, and a local head gradient system capable of at least 200 mT/m peak amplitude and 900 T/m/s slew rate. The system must also feature an 8-channel parallel transmit array, a minimum of 64 digital receiver channels, and a high-end reconstruction computer supporting real-time processing of 64-channel data. Award will be determined via a Best Value Tradeoff, prioritizing performance capability over the lowest cost. Key evaluation factors include local gradient and RF performance, research openness and development environment, compatibility with existing NIH workflows, and the contractor's relevant experience in delivering comparable 7T systems. Eligibility is strictly limited to offerors who attended the mandatory site visit on September 3, 2026. Proposals must be submitted in three distinct volumes covering technical specifications, past performance, and business/pricing. Large business offerors are required to provide a Small Business Subcontracting Plan. Final government acceptance is contingent upon successful on-site calibration and a continuous 24-hour imaging performance verification run. The contractor assumes all financial and operational risk for the delivery pathway and installation, with no post-award adjustments permitted for site complexities.
National Institutes Of Health Nichd

POSTED

4 days ago

DEADLINE

in 8 days
View Details
NAICS: 541714
New
Federal
Chemical, Biological, Radiological and Nuclear Advance Defense Enabling Network and Clinical Capability (CADENCC)
Solicitation # W911SR-26-9-CADENCC
The Department of the Army, through the Army Contracting Command Edgewood Contracting Division and the Joint Project Lead Enabling Technologies, is seeking preproposals for the Chemical, Biological, Radiological and Nuclear Advance Defense Enabling Network and Clinical Capability project. This initiative aims to accelerate clinical trial startups for CBRN defense readiness by implementing Master Protocols, utilizing innovative technologies for decentralized trial operations, and establishing a pre-positioned clinical trial site network. The project will primarily focus on Phase I and Phase II clinical trials for early treatment products, post-exposure prophylaxis, and pre-exposure prophylaxis, including those under the Animal Rule. This opportunity is issued under 10 USC 4022 Other Transaction Authority for a prototype project, with the potential for non-competitive follow-on production contracts for successful performers. Preproposals are due by 1500 hours on September 17, 2026, and must be limited to 10 pages. Evaluation will be based on technical merit, military relevance, technology readiness level 4 or above, regulatory compliance with FDA guidelines, and best overall value. Prospective awardees must be registered in the System for Award Management database.
W6QK Acc-Apg

POSTED

6 days ago

DEADLINE

in 7 days
View Details